Management of acute myeloid leukemia in Covid 19 era

The covid 19 pandemic has not spared patients with hematological malignancies. The hematologist community faces unprecedented challenge since the first identification of this new virus .in this study, we aim to describe characteristics and outcome of patients with acute myeloid leukemia (AML) diagnosed with covid 19 infection at different states of the disease.A total of 16 COVID-19-infected patients with AML were included; 4 (25%) patients were male. Median age was 37 years. 7 patients had a favorable, 7 intermediate and 2 high risk AML. we noted no case of hemorrhagic syndrome and only 1 patient developed a deep vein thrombosis. treatment of AML was postponed in 11 patients. 4 patients attracted SARS-COV2 infection undergoing intensive myelosuppressive chemotherapy. 2 patients had severe events and only 1 patient died. Patients with AML may show favorable outcomes of COVID 19 infection even while treated with intensive chemotherapy. Coronavirus disease has change life overnight and impact the management of patients suffering from cancer in general and particularly patients with AML, we need more studies to better understand different aspects of this tiny microorganism and its impact on the management of these patients